Oct. 18, 2024 – Older people who aren’t sure about whether to get the vaccine for respiratory syncytial virus (RSV) now have a new set of data to help them make up their minds. A large study ...

With cold and flu season around the corner, Doctors recommend receiving the RSV vaccine ahead of the holidays.

For adults aged 60 years or older, respiratory syncytial virus (RSV) vaccination is effective for preventing associat ...

such as lung or heart disease Adults who live in nursing homes Adults who got the RSV shot last year do not need to get it again this year; the vaccine is protective for at least two years.

Real-World Study Confirms RSV Vaccine's Protective Power for Seniors By Ernie Mundell HealthDay Reporter FRIDAY, Oct. 18, 2024 (HealthDay News) -- A global real-world study of the vaccine for ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against ...

Pima County Health Dept alerts about RSV season, urging high-risk groups to get vaccinated and describing symptoms and ...

It is always important to get vaccinated before flu season starts, but its extra important for seniors to get flu, COVID-19 and RSV vaccines. The CDC recommends those over sixty-five should get an ...

Notably, quarterly sales of the company’s RSV vaccine, which became a blockbuster after debuting last year, fell by more than 70% year over year, in part due to narrower U.S. recommendations for ...

AIM Vaccine Co., Ltd. Class H (HK:6660) has released an update. AIM Vaccine Co., Ltd. has secured clinical trial approval for its mRNA-based RSV vaccine, developed by its subsidiary Liverna ...

A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization. With U.S ...